JVMRX
Price
$30.99
Change
-$0.37 (-1.18%)
Updated
Dec 17 closing price
LMCTX
Price
$34.16
Change
-$3.67 (-9.70%)
Updated
Dec 17 closing price
Ad is loading...

JVMRX vs LMCTX

Header iconJVMRX vs LMCTX Comparison
Open Charts JVMRX vs LMCTXBanner chart's image
JHancock Disciplined Value Mid Cap R6
Price$30.99
Change-$0.37 (-1.18%)
VolumeN/A
CapitalizationN/A
Lord Abbett Mid Cap Stock R5
Price$34.16
Change-$3.67 (-9.70%)
VolumeN/A
CapitalizationN/A
JVMRX vs LMCTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMRX vs. LMCTX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Hold and LMCTX is a Hold.

FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 23.7B vs. LMCTX (1.23B). JVMRX pays higher dividends than LMCTX: JVMRX (0.93) vs LMCTX (0.70). JVMRX was incepted earlier than LMCTX: JVMRX (13 years) vs LMCTX (9 years). JVMRX (41.00) and LMCTX (41.00) have comparable annual turnover. LMCTX has a lower initial minimum investment than JVMRX: LMCTX (0) vs JVMRX (1000000). JVMRX annual gain was more profitable for investors over the last year : 11.22 vs. LMCTX (9.15). JVMRX return over 5 years is better than : 42.46 vs. LMCTX (26.09).
JVMRXLMCTXJVMRX / LMCTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years9 years-
Gain YTD13.2688.543155%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.7B1.23B1,921%
Annual Yield % from dividends0.930.70134%
Returns for 1 year11.229.15123%
Returns for 3 years18.018.02225%
Returns for 5 years42.4626.09163%
Returns for 10 years61.86N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSE6.581.06
+19.20%
Trinseo PLC
DRVN16.70-0.03
-0.18%
Driven Brands Holdings
UHS182.60-1.56
-0.85%
Universal Health Services
ONVO0.37-0.02
-5.38%
Organovo Holdings
ALT8.40-0.60
-6.67%
Altimmune